Evidence map›Paper›PMID 39735376›Full record

ArticleTransgender health2024

Exogenous Hormone Use Among Transfeminine Individuals in Chiang Mai, Thailand.

Malvina N Skorska, Pongpun Saokhieo, Lindsey T Thurston, Lindsay A Coome, Oranitcha Kaewthip, Suwat Chariyalertsak, Doug P VanderLaan

Abstract read
In one paragraph

Article in Transgender health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Malvina N SkorskaChild and Youth Psychiatry, Centre for Addiction and Mental Health, Toronto, Canada.
Pongpun SaokhieoResearch Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Lindsey T ThurstonDepartment of Psychology, University of Toronto Mississauga, Mississauga, Canada.
Lindsay A CoomeDepartment of Psychology, University of Toronto Mississauga, Mississauga, Canada.
Oranitcha KaewthipResearch Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Suwat ChariyalertsakFaculty of Public Health and Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Doug P VanderLaanChild and Youth Psychiatry, Centre for Addiction and Mental Health, Toronto, Canada.ORCID https://orcid.org/0000-0003-4498-9175

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This study describes Thai transfeminine individuals' exogenous hormone use. Methods: During the period May-July 2017, a survey was conducted among Thai transfeminine adults ( Results: Most participants (86.74%) used exogenous hormones. The mean (standard deviation) age of onset of use was 16.59 (3.79) years. A range of 1-15 brands with varying chemical composition were used. Hormones were typically procured from pharmacies (91.39%) and seldom physician prescribed (8.61%). Discontinuing use for 6 or more months was common (59.62%). Conclusions: Gender-affirming health care beginning in adolescence for Thai transfeminine individuals is needed.

Indexed as

gender-affirming health carehormone useThailandtransgender

Identifiers

PMID39735376
PMCPMC11669632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.